A novel genomic approach to herbicide and herbicide mode of action discovery.


Journal

Pest management science
ISSN: 1526-4998
Titre abrégé: Pest Manag Sci
Pays: England
ID NLM: 100898744

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 27 07 2018
revised: 12 09 2018
accepted: 26 09 2018
pubmed: 4 10 2018
medline: 16 1 2019
entrez: 4 10 2018
Statut: ppublish

Résumé

A herbicide with a new mode of action has not been commercialized for more than 30 years. A recent paper describes a novel genomic approach to herbicide and herbicide mode of action discovery. Analysis of a microbial gene cluster revealed that it encodes genes for both the biosynthetic pathway for production of the sesquiterpene aspterric acid and an aspterric acid-resistant form of dihydroxy acid dehydratase (DHAD), its target enzyme. Aspterric acid is weak compared with commercial synthetic herbicides, and whether DHAD is a good herbicide target is unclear from this study. Nevertheless, this genomic approach provides a novel strategy for the discovery of herbicides with new modes action. © 2018 Society of Chemical Industry.

Identifiants

pubmed: 30280497
doi: 10.1002/ps.5228
doi:

Substances chimiques

Herbicides 0
Heterocyclic Compounds, 3-Ring 0
aspterric acid 67309-95-9
Hydro-Lyases EC 4.2.1.-
dihydroxyacid dehydratase EC 4.2.1.9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

314-317

Informations de copyright

© 2018 Society of Chemical Industry.

Auteurs

Stephen O Duke (SO)

United States Department of Agriculture, Agricultural Research Service, Natural Products Utilization Research Unit, University, MI, USA.

Mark A Stidham (MA)

Resolute Therapeutics, Poway, CA, USA.

Franck E Dayan (FE)

Department of Bioagricultural Sciences and Pest Management, Colorado State University, Ft Collins, CO, USA.

Articles similaires

Coal Metagenome Phylogeny Bacteria Genome, Bacterial
Genome, Bacterial Virulence Phylogeny Genomics Plant Diseases
Humans Chondrocytes Osteoarthritis Matrix Metalloproteinase 13 Drug Discovery
1.00
Humans 2,4-Dichlorophenoxyacetic Acid Male Prostatic Neoplasms Middle Aged

Classifications MeSH